These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17308917)

  • 21. [Comparison and evaluation of enzyme-linked immunization assay kits with plague reduction neutralization test for detection of measles IgG antibody].
    Mao NY; Zhu Z; Jiang XH
    Zhongguo Yi Miao He Mian Yi; 2009 Jun; 15(3):215-8. PubMed ID: 20084884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods for screening the naturally acquired and vaccine-induced immunity to the measles virus.
    Christenson B; Böttiger M
    Biologicals; 1990 Jul; 18(3):207-11. PubMed ID: 2257133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measles-virus-neutralizing antibodies in intravenous immunoglobulins.
    Audet S; Virata-Theimer ML; Beeler JA; Scott DE; Frazier DJ; Mikolajczyk MG; Eller N; Chen FM; Yu MY
    J Infect Dis; 2006 Sep; 194(6):781-9. PubMed ID: 16941344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole blood samples as an alternative to serum for detection of immunity to measles virus by ELISA.
    Chakravarti A; Rawat D; Yadav S
    Diagn Microbiol Infect Dis; 2003 Dec; 47(4):563-7. PubMed ID: 14711476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status.
    Neumann PW; Weber JM; Jessamine AG; O'Shaughnessy MV
    J Clin Microbiol; 1985 Aug; 22(2):296-8. PubMed ID: 3897272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A study on measles immune status by ELISA].
    Li GQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Apr; 10(2):105-8. PubMed ID: 2736614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Declining measles antibodies in the era of elimination: Australia's experience.
    Gidding HF; Quinn HE; Hueston L; Dwyer DE; McIntyre PB
    Vaccine; 2018 Jan; 36(4):507-513. PubMed ID: 29269156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin M antibody response to measles virus following natural virus infection, primary vaccination, and reexposure to the virus.
    Nates S; Rey G; Giordano M; Medeot S; Depetris A; Boshell J; de Wolff CD
    Viral Immunol; 1997; 10(3):165-73. PubMed ID: 9344339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an enzyme-linked immunosorbent assay for immunoglobulin M antibodies against measles virus.
    Roodbari F; Roustai MH; Mostafaie A; Soleimanjdahi H; Foroshani RS; Sabahi F
    Clin Diagn Lab Immunol; 2003 May; 10(3):439-42. PubMed ID: 12738645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a high-throughput assay to measure measles neutralizing antibodies.
    Alvarado-Facundo E; Audet S; Moss WJ; Beeler JA
    PLoS One; 2019; 14(8):e0220780. PubMed ID: 31415584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of measles virus-specific neutralizing antibodies: evaluation of the syncytium inhibition assay in comparison with the plaque reduction neutralization test.
    Ward BJ; Aouchiche S; Martel N; Bertley FM; Bautista-Lopez N; Serhir B; Ratnam S
    Diagn Microbiol Infect Dis; 1999 Mar; 33(3):147-52. PubMed ID: 10092962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral fluid, a substitute for serum to monitor measles IgG antibody?
    Goyal A; Shaikh NJ; Kinikar AA; Wairagkar NS
    Indian J Med Microbiol; 2009; 27(4):351-3. PubMed ID: 19736406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.
    Haralambieva IH; Ovsyannikova IG; Vierkant RA; Poland GA
    Clin Vaccine Immunol; 2008 Jul; 15(7):1054-9. PubMed ID: 18463223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a new neutralization test for measles virus.
    Fujino M; Yoshida N; Kimura K; Zhou J; Motegi Y; Komase K; Nakayama T
    J Virol Methods; 2007 Jun; 142(1-2):15-20. PubMed ID: 17320979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of complement and difference of cell-based assay and ELISA in determination of neutralization capacity against mumps and measles virus.
    Brgles M; Kurtović T; Lang Balija M; Hećimović A; Mušlin T; Halassy B
    J Immunol Methods; 2021 Mar; 490():112957. PubMed ID: 33412172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus.
    Weigle KA; Murphy MD; Brunell PA
    J Clin Microbiol; 1984 Mar; 19(3):376-9. PubMed ID: 6371044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Standardization of neutralization tests using the COBL cell line and comparison with the particle agglutination test for measles serology].
    Korukluoğlu G; Yalçinkaya T; Ozkaya E; Kurtoğlu D; Gözalan A; Miyamura K
    Mikrobiyol Bul; 2002 Apr; 36(2):193-9. PubMed ID: 12652872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity and reproducibility of enzyme immunoassay for measles virus antibody detection.
    Rapicetta M; Proietti E; Morace G; Macchia T
    Microbiologica; 1983 Jul; 6(3):239-45. PubMed ID: 6355776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired neutralizing activity by transplacental measles antibodies in infants born to HIV-1-infected mothers.
    Farouk S; Navér L; Smedman L
    Acta Paediatr; 2012 Nov; 101(11):e500-4. PubMed ID: 22816388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decay of maternally derived measles antibody in central Turkey.
    Metintaş S; Akgün Y; Arslantaş D; Kalyoncu C; Uçar B
    Public Health; 2002 Jan; 116(1):50-4. PubMed ID: 11896637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.